PSAT1 and acute myeloid leukemia: The results demonstrated that HRAS, CXCL2, SLC38A1, PGD, ENPP2, ACSL3, DDIT4 and PSAT1 mRNA levels were upregulated in AML specimens, while PHKG2, HSD17B11, STEAP3 and ARNTL was downregulated (Figure S3).